Investigation of factors associated with allergic transfusion reaction due to platelet transfusion and the efficacy of platelets resuspended in BRS‐A in adult patients
Authors:
- 18 September 2019
- journal article
- research article
- Published by Wiley in Transfusion
- Vol. 59 (11) , 3405-3412
Abstract
BACKGROUND Although allergic transfusion reactions (ATRs) resulting from platelet concentrate (PC) are a common adverse reaction, the mechanism underlying ATRs has not been fully elucidated. Plasma‐replaced PC suspended in bicarbonate Ringer's solution and anticoagulant citrate dextrose solution A (RPC‐B) is effective for preventing ATRs in children in Japan; however, there is not enough evidence in adult populations. STUDY DESIGN AND METHODS We conducted a retrospective analysis focused on factors associated with ATRs developing from PC transfusions in adult patients in a single institution between 2015 and 2018. The clinical efficacy of RPC‐B for adult patients was also analyzed. RESULTS In total, 4,677 untreated regular PC products in plasma were transfused into 914 patients. ATRs developed in 65 patients (7.1%) treated with 92 PC products (2.0%). Multivariate analysis revealed that patients who were elderly, diagnosed with a non‐hematological disease, and who received a transfusion of fresh‐frozen plasma and red blood cell concentrate products together with PC products had lower frequencies of ATRs. Although 40 patients received 490 RPC‐B transfusions, six ATRs (1.2%) were confirmed in five patients (12.5%). The ATR frequency was not significantly lower in the analysis of all patients; however, ATRs in patients with hematological diseases were lower in terms of both the patient and product numbers. Corrected count increments (24 hr) were also within an acceptable range in patients with hematological diseases. CONCLUSION Several patient‐specific factors may be associated with the development of ATRs from PC transfusion. Because RPC‐B appears to efficiently prevent ATRs, even in adult patients, safe and efficient transfusions may be performed by using RPC‐B preferentially depending on the patient's risk factors.Keywords
This publication has 34 references indexed in Scilit:
- Replaced platelet concentrates containing a new additive solution, M-sol: safety and efficacy for pediatric patientsTransfusion, 2012
- Current understanding of allergic transfusion reactions: incidence, pathogenesis, laboratory tests, prevention and treatmentBritish Journal of Haematology, 2012
- Investigation of the freely available easy-to-use software ‘EZR’ for medical statisticsBone Marrow Transplantation, 2012
- Comparative in vitro evaluation of apheresis platelets stored with 100% plasma versus bicarbonated Ringer's solution with less than 5% plasmaTransfusion, 2012
- Allergic agonists in apheresis platelet products are associated with allergic transfusion reactionsTransfusion, 2011
- Allergic transfusion reactions to platelets are associated more with recipient and donor factors than with product attributesTransfusion, 2011
- Platelet components associated with acute transfusion reactions: the role of platelet-derived soluble CD40 ligandBlood, 2008
- Blood transfusions in children: a multi‐institutional analysis of practices and complicationsTransfusion, 2007
- Acute transfusion reactions in the pediatric intensive care unitTransfusion, 2006
- The Role of the Plasma from Platelet Concentrates in Transfusion ReactionsNew England Journal of Medicine, 1994